A general thread on the PACE trial!

Discussion in 'Psychosomatic research - ME/CFS and Long Covid' started by Esther12, Nov 7, 2017.

  1. Barry

    Barry Senior Member (Voting Rights)

    Messages:
    8,412
    As I've sussed this, hope you don't mind me barging in @Sly Saint ...
    upload_2018-11-10_23-33-42.png

    Page 26.
     
  2. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    15,105
    Location:
    London, UK
    Thanks
     
    MeSci and Barry like this.
  3. Adrian

    Adrian Administrator Staff Member

    Messages:
    6,560
    Location:
    UK

    Pace did have some doctor based evaluations and I think for the CGI score they substituted in the assessors value when the patients value was missing.
     
    Barry and MEMarge like this.
  4. Hoopoe

    Hoopoe Senior Member (Voting Rights)

    Messages:
    5,417
    https://ora.ox.ac.uk/catalog/uuid:b8a4b340-4d03-41dc-8351-9cb462ef1ba4/download_file?file_format=pdf&safe_filename=Controversy+over+exercise+therapy+for+chronic+fatigue+syndrome+-+Continuing+the+debate.pdf&type_of_work=Journal+article

    You can see how the PACE authors respond to criticism.

    They refer to the Wilshire et al paper as "results of a secondary analysis of the data" that "reports the proportions of participants meeting various criteria for recovery". They try to obfusctae that Wilshire et al used their own published protocol for this analysis.

    They dismiss the criticism regarding the newsletter, essentially saying that it didn't unduly favor any treatment. It's still a mistake to bias participant expectations at all, and whether this truly didn't favour certain treatments more than other is unclear and very debatable. "Therapists" are mentioned several times in glowing comments which cannot refer to the control group. A doctor praises the therapy. It's also mentioned that NICE recommends CBT, GET and activity management (but activity management is not adaptive pacing therapy or pacing, NICE describes it as form of graded activity). Yet they base their claims of efficacy on the difference between the control group and CBT/GET groups.

    Here they pretend that a criticism concerning the introducing of bias during the trial could be refuted by referring to baseline expectations. It cannot. They also fail to mention that the control group had much lower expectations even at baseline. Again, they base their claims of efficacy on the difference between the control group and CBT/GET groups.
     
    Last edited: Nov 11, 2018
    MEMarge, andypants, Inara and 5 others like this.
  5. Lucibee

    Lucibee Senior Member (Voting Rights)

    Messages:
    1,498
    Location:
    Mid-Wales
    Arguably that could create more bias, not less.

    CGI and attendance, although filled in on anonymised forms, was recorded by the therapist - they had to know the participant to be able to do that.
    It was not a blinded assessment.
     
    MEMarge, andypants, rvallee and 5 others like this.
  6. Hoopoe

    Hoopoe Senior Member (Voting Rights)

    Messages:
    5,417
    @Lucibee what do you think about the original PACE protocol allowing for a later formulation of an exact statistical analysis plan? That sounds like giving themselves permission to make unspecified changes to the statistical analysis.

    They also only published this statistical plan in 2013, and we are asked to trust that they never peeked at the data before finalizing their plan. They probably didn't need to: they knew from the NICE trial that the rehabilitation program it tested did nothing (and it included graded return to activity).
     
    Last edited: Nov 11, 2018
    MEMarge, andypants, rvallee and 3 others like this.
  7. Lucibee

    Lucibee Senior Member (Voting Rights)

    Messages:
    1,498
    Location:
    Mid-Wales
    There were so many problems with the original protocol anyway, I'm really not sure it makes much difference. We sometimes get a bit obsessed that they haven't followed the rules, and forget that what they *did* intend to do didn't actually stand up to much either.
     
    MEMarge, andypants, Sean and 9 others like this.
  8. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    13,598
    Location:
    Canada
    Yeah, that's a weird one. It's still a self-evaluation. That there would be an evaluator involved at all influences the outcome, which is of course the whole point when the treatment itself is gaslighting.
     
    MEMarge and andypants like this.
  9. Mithriel

    Mithriel Senior Member (Voting Rights)

    Messages:
    2,816
    I was originally diagnosed as having migraine "with more of the funny symptoms and less of the headache" In about 1982 I was part of a clinical trial in the psychology department of my local hospital. I think it might have been an early form of CBT against more traditional treatments as we made a list of certain concerns and then looked at them one at a time.

    Apart from needing reminded my problems in shops were not because of agrophobia but headaches from the strip lighting it was not too bad and useful for some things like making plans and lists which have helped me live with ME and the usual relaxation exercises.

    (When we were done, I asked him if being on the trial would mean that every ache I had from now on would be put down to psychological problems and he said, maybe but I would know they weren't, which I have kept in mind in the dark days of ME :))

    Anyway, back to the point. At the start I was assessed by a different psychologist with a standard set of questions. This was repeated at the end by the same guy. He did not know what arm of the trial I had been in so I always felt it was properly blinded, though there might be flaws with it that I can't see.
     
    MEMarge, andypants and Trish like this.
  10. Lucibee

    Lucibee Senior Member (Voting Rights)

    Messages:
    1,498
    Location:
    Mid-Wales
    If you knew which arm you were in, it wasn't properly blinded.
     
    andypants, Sly Saint, Dolphin and 2 others like this.
  11. Mithriel

    Mithriel Senior Member (Voting Rights)

    Messages:
    2,816
    No, he wouldn't tell me what the trial was about, It is just what I think now when I look back.
     
    Trish likes this.
  12. Lucibee

    Lucibee Senior Member (Voting Rights)

    Messages:
    1,498
    Location:
    Mid-Wales
    Oh good. At least they got your informed consent to participate then... :facepalm:
     
    MEMarge, andypants, Mithriel and 4 others like this.
  13. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    9,889
    Location:
    UK
    I know that people have already reported that some of the links to the documentation for the PACE trial no longer work.
    Just going thro the Sharpe/Wessely/Mike Godwin twitter thread here on S4ME and picked up that the link Wessely gives for the PACE trial is now a dead link.
    The current link is here:
    https://www.qmul.ac.uk/wolfson/research-projects/current-projects/projects/pace-trial.html

    (some of the links still don't work eg the one to the Cochrane review on Exercise)
     
    Lucibee, Sean, andypants and 2 others like this.
  14. Tom Kindlon

    Tom Kindlon Senior Member (Voting Rights)

    Messages:
    2,253
  15. Lucibee

    Lucibee Senior Member (Voting Rights)

    Messages:
    1,498
    Location:
    Mid-Wales
    Interesting that the top 2 items under "Latest news" have lost their links now...

    I seem to remember that analysis getting pretty similar results to those of Wilshire et al, but they disappeared from the website soon afterwards. Did anyone capture it before it went?
     
  16. Tom Kindlon

    Tom Kindlon Senior Member (Voting Rights)

    Messages:
    2,253
     

    Attached Files:

  17. Lucibee

    Lucibee Senior Member (Voting Rights)

    Messages:
    1,498
    Location:
    Mid-Wales
    Thanks @Tom Kindlon . I had misremembered. It was improvement they looked at. The results are somewhat affected by their definition of "improvement", which also included a 50% increase from baseline (in PF) - which is very sensitive to regression to the mean, particularly in those with low scores at baseline.

    Looking back at this, I'm also struck by this combination of info:

    In the Protocol (Background, Introduction [section 4.1]), they say,
    Yet, in their per-protocol analysis, only a fifth of those on CBT or GET improved by one year, even with subjective enhancement. And their study provided no way to determine whether anyone returned to pre-morbid functioning.
     
  18. Esther12

    Esther12 Senior Member (Voting Rights)

    Messages:
    4,393
    Good point.

    For anyone interested, these are the references:

    3. Wessely SC, Hotopf M, Sharpe M: Chronic fatigue and its syndromes. 1998, Oxford , Oxford University Press, 428-Google Scholar

    9. Joyce J, Hotopf M, Wessely S: The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med. 1997, 90: 223-233. View ArticleGoogle Scholar

    I'd assumed that they'd have cited this 2005 review on prognosis that had similar figures on recovery (https://academic.oup.com/occmed/article/55/1/20/1392403), but maybe that came out after the protocol was written, and I've not read that 1997 one. The evidence in the 2005 one was still less than overwhelming.
     
    Last edited: Dec 1, 2018
  19. Lucibee

    Lucibee Senior Member (Voting Rights)

    Messages:
    1,498
    Location:
    Mid-Wales
    Interesting that Hotopf's review abstract makes the point that this is improvement *without* any systematic intervention, so to find such a poor response in the PACE per-protocol analysis is doubly damning.
     
  20. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,860
    Location:
    Australia
    It's clear as mud. They need to be much clearer about what they are referring to.

    The key is the timeframe - the claim that one third improve by one year most likely is based on time of acute onset - a third improve somewhat until their illness plateaus.

    But the PACE trial did not involve capturing acute onset and diagnosis in a community/population sample and subsequent treatment, so the two improvement claims are not comparable.
     

Share This Page